Liz Lightstone Imperial College London and Hammersmith HospitalUnited Kingdom

Professor Liz Lightstone completed medical training at Cambridge University and Kings College Hospital Medical School and her renal training at the Hammersmith Hospital. She is Prof of Renal Medicine at Imperial College London. Her main research interests are in improving outcomes for patients with lupus nephritis (LN) and pregnancies in women with kidney disease. She also advocates to reduce health inequities in renal medicine, to hear the patient voice in research and support women in nephrology. She is an elected member of the Women in Nephrology Executive Council. She is global co-chair of the SONG-GD steering committee, co-chairs the UK Kidney Research Consortium GN Clinical Study Group, established the Renal RaDar CKD and pregnancy rare disease group, is a member of the OMERACT 2022 SLE Working Group and the International Working Group on Glomerular Diseases and Pregnancy. She has contributed to guidelines on LN and Pregnancy and Kidney Disease, advice NICE in these areas and is on the Advisory Board of Nature Rev Nephrology. She is a Trustee of Kidney Research UK and serves on their Research Strategy and Nominations and Governance Committees. She has had major roles in education but is particularly proud of mentoring numerous trainees over many years and is a mentor on the 2021 ISN Emerging Leaders Programme. In the past year she has developed expertise in the management of severe COVID pneumonitis, co-chairs her hospitals COVID Treatment and Guideline Group, co-chaired a COVID Rapid Synthesis of Evidence group to guide clinical decisions, and coordinated the vaccination programme for kidney patients in West London.

1 APRIL 2023

Time Session
14:15
15:15
Liz Lightstone Chairperson Imperial College London and Hammersmith HospitalUnited Kingdom
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • STOP-ACEi Study
    Sunil Bhandari Speaker Hull & East Yorkshire Hospitals NHS Trust United Kingdom
  • Q and A
  • DETERMINANTS OF THE EFFECTS OF SGLT2i ON PROGRESSION OF CKD: FURTHER RESULTS FROM THE EMPA-KIDNEY TRIAL
    Natalie Staplin Free Communication University of OxfordUnited Kingdom
  • Q and A
  • SPARSENTAN REDUCES PROTEINURIA IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IGAN): INTERIM RESULTS OF THE PROTECT STUDY
    Muh Geot Wong Speaker University of SydneyAustralia
  • Q and A
  • RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL OF ARTESUNATE IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    Jianwen YU Free Communication The First Affiliated Hospital of Sun Yat-sen UniversityChina
  • Q and A
Plenary Halls 2 & 3

31 MARCH 2023

Time Session
17:00
18:00
  • Acute Kidney Injury
    Letizia De Chiara Moderator letizia.dechiara@unifi.itUniversità degli studi di FirenzeItaly
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 1
    Chirag Parikh Moderator chirag.parikh@jhmi.eduJohns Hopkins UniversityUnited States
  • Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
    Marques Ng Moderator The Chinese University of Hong KongHong Kong, China
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 1
    Chuan-Ming Hao Moderator Huashan Hospital Fudan UniversityChina
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 2
    Vivek Kumar Moderator PGIMER, ChandigarhIndia
  • Chronic Kidney Disease Diagnosis, Classification and Progression 1
    Sydney Tang Moderator The University of Hong KongHong Kong, China
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 1
    Matthias Kretzler Moderator kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 1
  • Clinical Glomerulonephritis 2
    Warangkana Pichaiwong Moderator Rajavithi HospitalThailand
  • Covid-19 and AKI
    Neil Boudville Moderator Sir Charles Gairdner HospitalAustralia
  • Covid-19 and KF (Kidney Failure)
    Sarinya Boongird Moderator Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand
  • Diabetic Kidney Disease, Drugs and Treatments 1
    John Cijiang He Moderator United States
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 1
    Abduzhappar Gaipov Moderator Nazarbayev University School of MedicineKazakhstan
  • Epidemiology, Outcomes and Health Services Research in Dialysis 1
    Geraldo Bezerra da Silva Jr Moderator University of FortalezaBrazil
  • Experimental Models- Glomerulonephritis
  • Haemodialysis, Haemodiafiltration and Vascular Access 1
    Anil Agarwal Moderator akagarwalmd@gmail.comUniversity of California San Francisco at Fresno and VA Central California Health Care SystemUnited States
  • Kidney in Pregnancy and Post-Partum
    Liz Lightstone Moderator Imperial College London and Hammersmith HospitalUnited Kingdom
  • Kidney Transplantation and Transplant Immunology 1
    Eric Rondeau Moderator Sorbonne Université Hopital TenonFrance
  • Kidney Transplantation and Transplant Immunology 2
    Ahmed Kalebi Moderator Ahmed Kalebi ConsultancyKenya
  • Online Learning
    Amnart Chaiprasert Moderator Thailand
  • Other AKI
    Watanyu Parapiboon Moderator Maharat Nakhonratchasima HospitalThailand
  • Other CKD 1
    Juliana Chan Moderator The Chinese University of Hong KongHong Kong, China
  • Peritoneal Dialysis 1
    Xueqing Yu Moderator Guangdong Provincial People's HospitalChina
  • Social Media
    Sibel Bek Moderator Kocaeli University HospitalTurkey
  • Special Challenges in the Burden and Management of CKD in Developing Countries
    Kearkiat Praditpornsilpa Moderator kearkiat@hotmail.comThailand
Ballroom 2-3-4-Exhibition Hall

Poster Session, 31 March 2023

Time Session
17:00
18:00
Poster Session 1: Acute Kidney Injury
Liz Lightstone Moderator Imperial College London and Hammersmith HospitalUnited Kingdom
Exhibition Hall